SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037482
Filing Date
2016-08-15
Accepted
2016-08-15 16:27:41
Documents
67
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20160630_10q.htm 10-Q 739166
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10420
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10112
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5419
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5422
12 dffn20160630_10qimg001.jpg GRAPHIC 14883
  Complete submission text file 0001437749-16-037482.txt   4391791

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS dffn-20160630.xml EX-101.INS 749501
7 EXHIBIT 101.SCH dffn-20160630.xsd EX-101.SCH 54750
8 EXHIBIT 101.CAL dffn-20160630_cal.xml EX-101.CAL 28923
9 EXHIBIT 101.DEF dffn-20160630_def.xml EX-101.DEF 407876
10 EXHIBIT 101.LAB dffn-20160630_lab.xml EX-101.LAB 313452
11 EXHIBIT 101.PRE dffn-20160630_pre.xml EX-101.PRE 417527
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24477 | Film No.: 161833151
SIC: 2834 Pharmaceutical Preparations